InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (28 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
28
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Barrow Robert. Officer active across 2 companies, notably Mind Medicine (MindMed) Inc.. Cumulatively, 41 disclosures have been published. Breakdown: 2 buys · 28 sells. Total volume traded: €2m. Activity tracked since 15 January 2022. The latest transaction was filed on 12 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Barrow Robert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
375,000 shares0Common SharesSEC:0001193125-26-345839:0
29,208 sharesCommon SharesSEC:0001193125-26-285562:0
375,000 sharesCommon SharesSEC:0001193125-26-276882:0
24,431 shares@ US$18.47100.0% of flowCommon SharesSEC:0001193125-26-126825:0
320,000 shares0Common SharesSEC:0001193125-26-039571:0
25,791 shares@ US$13.146915.8% of flowCommon SharesSEC:0001193125-25-335483:0
25,797 shares@ US$9.7714.1% of flowCommon SharesSEC:0001193125-25-220847:0
26,491 shares@ US$6.8011.8% of flowCommon SharesSEC:0000950170-25-090428:0
21,208 shares@ US$6.749.8% of flowCommon SharesSEC:0000950170-25-045397:0
350,000 shares0Common SharesSEC:0000950170-25-038801:0
19,106 shares@ US$7.4310.1% of flowCommon SharesSEC:0001104659-24-132167:0
19,771 shares@ US$5.987.8% of flowCommon SharesSEC:0000950170-24-109449:0
500 shares@ US$6.310.2% of flowCommon SharesSEC:0000950170-24-099351:0
Canonical exit: 17 Nov 2024 (T+90)
500 shares@ US$6.120.2% of flowCommon SharesSEC:0000950170-24-099351:1
Canonical exit: 18 Nov 2024 (T+90)
15,659 shares@ US$7.227.8% of flowCommon SharesSEC:0000950170-24-077495:0
16,519 shares@ US$9.5010.7% of flowCommon SharesSEC:0000950170-24-036572:0
13,237 shares@ US$3.633.2% of flowCommon SharesSEC:0000950170-23-073069:0
5,268 shares@ US$3.572.7% of flowCommon SharesSEC:0000950170-23-049779:0
7,086 shares@ US$3.191.5% of flowCommon SharesSEC:0000950170-23-030256:0
8,416 shares@ US$3.211.8% of flowCommon SharesSEC:0000950170-23-030256:1
400,000 shares0Common SharesSEC:0001209191-23-019896:0
8,273 shares@ US$3.512.0% of flowCommon SharesSEC:0000899243-23-006786:0
3,861 shares@ US$2.690.7% of flowCommon SharesSEC:0000899243-22-039214:0
1,207 shares@ US$2.810.3% of flowCommon SharesSEC:0000899243-22-034146:0
1,220 shares@ US$3.110.3% of flowCommon SharesSEC:0000899243-22-033749:0
25 of 41 declarations
About Barrow Robert
Barrow Robert has 40 filings in total. Across the 40 sampled recent filings, the aggregated amounts indicate EUR 5,596 of buys and EUR 1,958,889 of sells, with filings ranging from 2022-01-19 to 2026-06-26. He is Chief Executive Officer at Mind Medicine (MindMed) Inc. and at Definium Therapeutics, Inc., and the dominant transaction nature is Sell.
